Retrospective analysis of long term lanthanum carbonate therapy

Retrospective analysis of long term lanthanum carbonate therapy - Long Term LAnthanum Carbonate Therapy (Lot-LACT)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015227

Enrollment

Registered

2014-09-25

Start date

2014-09-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease undergoing hemodialysis treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who completed the long-term clinical study of lanthanum carbonate (3 years). The patients of filling the following all criteria and having ability for agreement

Exclusion criteria

Exclusion criteria: The patients who did not complet the long-term clinical study of lanthanum carbonate (3 years). The patients without agreement

Design outcomes

Primary

Measure	Time frame
Adverse event	—

Secondary

Measure	Time frame
Therapeutic effect on hyperphosphatemia	—

Countries

Japan

Contacts

Public ContactShigeo Negi

Wakayama Medical University Division of Nephrology

shigeon@wakayama-med.ac.jp+81-73-441-0639

Outcome results